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Recent reports have demonstrated various cardiovascular and neurological benefits associated with the consumption of foods rich in anthocyani-
dins. However, information regarding absorption, metabolism, and especially, tissue distribution are only beginning to accumulate. In the present
study, we investigated the occurrence and the kinetics of various circulating pelargonidin metabolites, and we aimed at providing initial infor-
mation with regard to tissue distribution. Based on HPLC and LC-MS analyses we demonstrate that pelargonidin is absorbed and present in
plasma following oral gavage to rats. In addition, the main structurally related pelargonidin metabolite identified in plasma and urine was pelar-
gonidin glucuronide. Furthermore, p-hydroxybenzoic acid, a ring fission product of pelargonidin, was detected in plasma and urine samples
obtained at 2 and 18 h after ingestion. At 2 h post-gavage, pelargonidin glucuronide was the major metabolite detected in kidney and liver,
with levels reaching 0·5 and 0·15 nmol pelargonidin equivalents/g tissue, respectively. Brain and lung tissues contained detectable levels of the
aglycone, with the glucuronide also present in the lungs. Other tissues, including spleen and heart, did not contain detectable levels of pelargonidin
or ensuing metabolites. At 18 h post-gavage, tissue analyses did not reveal detectable levels of the aglycone nor of pelargonidin glucuronides.
Taken together, our results demonstrate that the overall uptake of the administered pelargonidin was 18% after 2 h, with the majority of the
detected levels located in the stomach. However, the amounts recovered dropped to 1·2% only 18 h post-gavage, with the urine and faecal content
constituting almost 90% of the total recovered pelargonidin.
Anthocyanidin: Pelargonidin: Absorption: Distribution: Metabolism
As part of the flavonoid family, anthocyanins are polyphenolic
compounds that are widely distributed among pigmented fruit
and vegetables. Anthocyanidins are particularly abundant in
berries, such as blueberry and blackcurrant, as well as in red
wine, thus their presence in the diet can be significant. As
potential components of the human diet, previous research
on anthocyanidins has concentrated on their biological activi-
ties, and included the assessment of possible health benefits.
For example, previous dietary interventions in man and ani-
mals have demonstrated that the consumption of anthocya-
nin-rich red wine (Renaud & de Lorgeril, 1992) or blueberry
extract (Joseph et al. 1999) may exert beneficial effects by
lowering the risk of CHD, and by retarding age-related
declines in neurological function, respectively.
To evaluate the health benefits of anthocyanidins in man it
is important to understand their absorption, metabolism, tissue
distribution and excretion. Several studies have shown that
anthocyanins are absorbed as glycosides that could be
recovered from plasma and urine after oral administration
(Cao & Prior, 1999; Miyazawa et al. 1999). However, the
bioavailability of anthocyanins is very limited and their
metabolism is still not fully understood. In addition, only a
few studies (Tsuda et al. 1999; Matsumoto et al. 2001) have
quantitatively evaluated the absorption of anthocyanins using
purified compounds (directly administered using a defined
dose) as opposed to feeding enriched foods or food extracts.
To date, there are few data available with regard to anthocya-
nidin distribution among various body tissues where they could
exert their biological effects through antioxidant potential, by
association with the cell membrane or through direct intracellu-
lar mechanisms. Anthocyanidins are known to be stable under
acidic conditions but rapidly broken down under neutral con-
ditions (Brouillard, 1988) such as those encountered in vivo. It
is thus necessary to characterise and to quantify anthocyanin
metabolites, including ring-fission products, as well as the
ingested form of anthocyanidins. In the present study, we
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investigated metabolism and distribution of the strawberry
anthocyanin, pelargonidin, after gavage into rats, and assessed
the effect of time on the nature and the circulating levels of its
metabolites.
Experimental methods
Animals
Male Sprague-Dawley rats (250 g) were obtained from the
Comparative Biology Unit at the Royal Free and University
College Medical School, and maintained on standard rat
chow (Diet RM1; SDS Ltd, Witham, UK). Two groups of
rats (n 6) were administered pelargonidin (Extrasynthese,
purity 99·82%), dissolved in 50% aqueous ethanol, in a
dose of 50mg/kg body weight and killed 2 or 18 h post-
gavage. Three animals served as control group and received
only 50% aqueous ethanol. In all groups, animals were
fasted for 4 h before pelargonidin administration.
At the selected times, animals were anaesthetised by intra-
peritoneal injection of pentobarbitone sodium (90mg/kg;
Sagital; Rhone-Merieux, Harlow, UK). Heparin (0·3ml,
5000 IU/ml; CP Pharmaceuticals Ltd, Wrexham, UK) was
injected via a tail vein injection to reduce blood clotting fol-
lowed by collection of 2ml blood by cardiac puncture into
heparinised tubes. Animals were exsanguinated with 200ml
ice-cold heparinised 0·9% (w/v) saline and the blood-free
organs were dissected out immediately. Plasma samples
were separated by centrifugation at 600 g for 30min and
immediately acidified with 0·44 M-trifluoroacetic acid (TFA)
in the ratio 5:1. The Hb concentrations in the cardiac blood
sample and exsanguinated fluid was measured using a Hb
assay kit (Sigma, Poole, UK) to allow calculation of blood
volume. The removed tissues, liver, kidneys, spleen, heart,
small intestine, large intestine, lung and brain, were weighed
and then homogenised in TFA (10 volumes/g tissue) using a
Ultra Turrax homogeniser (Janke &Kunkel, Staufen, Germany)
for 40 s. Urine and faeces from rats were collected in metabolic
cages containing 1·5ml TFA to prevent the degradation of pelar-
gonidin. Intestinal contents were drained by finger pressure,
flushed with TFA, and contents kept for analysis.
Sample preparation
Plasma (150ml) was de-proteinised with 30ml 20% (w/v) TCA
then extracted with 200ml ice-cold methanol. HPLC analysis of
re-extracted pellet showed no detectable retained material.
Solvents contained in the extract obtained after centrifugation
were evaporated under N and the residue was dissolved in
250ml 20% (v/v) methanol in 0·44 M-TFA for quantitative
HPLC analysis. An additional aliquot of plasma was loaded
on to an ODS solid extraction cartridge (Sep-Pak C18;
Waters, Milford, MA, USA) after the column was washed
with 3ml methanol and equilibrated with 6ml water–
methanol–acetic acid (94:5:1, by vol.) prior to the application
of the sample. Following the sample application, the cartridge
was washed with the same equilibrating mixture and the
anthocyanins were eluted from the cartridge material with
2ml methanol. The extract was dried under N, and the residue
dissolved in 250ml 20% (v/v) methanol in 0·44 M-TFA.
Urine samples were filtered through a micropore filter
(Millex-GP, 0·22mm filter unit; Millipore, Billerica, MA,
USA). Extraction of pelargonidin and its metabolites from
rat tissues was performed by mixing the homogenates with
an equal volume of ice-cold methanol followed by vigorous
vortexing for 1min. The methanolic extract obtained after
centrifugation was dried under vacuum at 308C by rotary
evaporation and then the extracts were treated as described
earlier.
Quantitative determination of pelargonidin and its metab-
olites was based on external standards. An internal standard,
rutin, was added to the samples before extraction and to the
external standards to a final concentration of 5mM. Calibration
curves were conduced over the range of 0·5–20mmol/l. Peak
area ratios (compound/internal standard) were plotted against
concentration of the compound/metabolite. The concentration
of pelargonidin glucuronide was calculated using peak area of
standard pelargonidin aglycone and expressed as pelargonidin
equivalents as previously used for calculation of anthocyani-
din metabolites (Felgines et al. 2002; Wu et al. 2002). Cali-
bration curves obtained were linear over the entire range
with correlation coefficient values $0·995.
Methods of analysis
HPLC analysis was undertaken using a Waters system
(Milford, MA, USA) consisting of controller 600, auto sam-
pler 717 plus, photodiode array detector 996 and on-line
degasser. Samples were analysed on a Zorbax SB-C18
column (4·6 £ 250mm, with 5mm particle size and a guard
column of the same material, 4·6 £ 15mm). Column tempera-
ture was set at 30 8C. Mobile phase A consisted of 5% formic
acid aqueous solution and mobile phase B of pure methanol.
The gradient applied was as follows: from 0 to 5min 95%
A and 5% B, from 5 to 40min to 100% B, from 40 to
45min 100% B, and from 45·1min 90% A and 10% B. Run
time was 60min followed by a 10min delay prior to the next
injection. Components were identified according to retention
times and UV/visible spectra. Detection of pelargonidin was
undertaken at 520 nm, internal standard at 300 nm and pheno-
lic acids at 260 nm. LC-MS analysis was employed using a
Finnigan LCQ Deca XP quadrupole ion trap mass spec-
trometer (San Jose, CA, USA). Separation was performed
using a C18 column (50 £ 2·5mm; Phenomenex, Schlieren,
Switzerland) with the following gradient (phase A: 0·1%
formic acid in water, phase B: 50% acetonitrile in water,
0·1% formic acid). The LC-MS gradient was 0–5min
100% A, 5–40min from 100% A to 50% A, 40–60min to
0% A, 60–65min 0% A. Compounds were detected using a
full ion scan and identified by performing product ion scans
on selected ions. GC-MS analysis was used as described pre-
viously (Rechner et al. 2002) to confirm the identity of pheno-
lic acids detected by HPLC.
Calculations and statistics
Values are given as means with their standard errors of the
mean. Statistical analysis was performed using an unpaired t
test (Instat) and considered significant at P,0·05.
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Results
The present study investigated the metabolism of pelargonidin
after oral administration to rats. HPLC analysis with
photodiode array detection was employed to identify the
nature of metabolites (Fig. 1). Whereas no anthocyanins
were detected in untreated controls, the oral administration
of pelargonidin to rats led to the detection of a circulating
Fig. 1. Representative chromatograms of tissues obtained from pelargonidin-fed rats. (a), Small intestine extract at 520nm: peak 1, pelargonidin-O-b-D-glucuronides; peak
2, pelargonidin. (b), Plasma extract at 520nm. (c), Urine at 260nm: peak 3, p-hydroxybenzoic acid. (d), Plasma at 260nm: peak 4, unidentified. AU, absorbance units.
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anthocyanidin at 2 h post-ingestion. This compound was
detected by HPLC, and eluted at a retention time of
40·0min (peak 2), which corresponds to the retention time
of free pelargonidin aglycone. In addition, a major peak at
29·2min (peak 1), which partially co-eluted with a minor
peak, was also detected in the gastrointestinal tract, plasma
and urine. Similarities regarding their absorbance spectra as
well as the difficulties we experienced in attempting to com-
pletely separate these two peaks using various HPLC gradient
conditions may indicate that these compounds are structurally
related. Both compounds were more hydrophilic than pelargo-
nidin, and thus were predicted to represent glucuronidated
Fig. 2. MS/MS trace of small intestine extract obtained from pelargonidin-gavaged rats. The trace shows pelargonidin (m/z ¼ 271) eluting at 27·18min and pelar-
gonidin-O-glucuronide (m/z ¼ 447) with a retention time of 23·34min. The spectrum shows a single fragment at m/z ¼ 271, the Mþ ion of the aglycone, indicating
the neutral loss of glucuronic acid. The insert shows the spectrum of the base peak (Mþ).
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derivatives of pelargonidin. Thus, a subsequent LC-MS/MS
analysis of the isolated peaks was undertaken to confirm the
molecular mass for pelargonidin glucuronides (Fig. 2). Two
major peaks are detected at 530 nm, one for pelargonidin
with m/z ¼ 271 (retention time 27·18min), preceded by a
more polar glucuronide signal m/z ¼ 447 (retention time
23·53min) (Fig. 2). The product ion spectrum of the major
pelargonidin-glucuronide shows the neutral loss of glucuronic
acid, and therefore the major peak is the Mþ ion of the
aglycone.
HPLC chromatograms of urine samples collected for 18 h
post-gavage at 260 nm (Fig. 1(c)) also revealed the presence
of peak 3, eluting at 18min. This peak was identified as
p-hydroxybenzoic acid by comparison with an authentic stan-
dard compound, and based on retention times and UV spectra
as well as by GC-MS analysis following derivatisation
(Fig. 3). This phenolic acid was also detected in plasma samples
obtained at 2 or 18 h post-ingestion. Fig. 4 shows two modes of
the C-ring fission of pelargonidin, which yield ultimately the
detected product, p-hydroxybenzoic acid. The dotted line
shows breakage of the C-ring between C8a-O1 and C2-C3 lead-
ing to formation of p-hydroxybenzoic acid directly. However,
as shown by the dashed line, breakage of the C-ring can also
occur between O1-C2 and C4-C4a, leading to the formation
of p-hydroxyphenyl propionic acid, which could be subjected
to b-oxidation leading to formation of p-hydroxybenzoic acid,
as previously described by Scheline (1991).
In addition, 2 h plasma samples revealed the presence of an
additional peak eluting at 35·2min (Fig. 1(d)), which was
found to be present at lower levels after 18 h, but which was
not detectable in any of the control samples. This finding
may be indicative for the presence of another metabolic pro-
duct resulting from pelargonidin intake. However, we were
not able to structurally identify this compound as a pelargoni-
din metabolite.
Levels of pelargonidin metabolites at 2 and 18 h were
calculated in plasma and tissues and expressed as nmol
pelargonidin equivalents/ml plasma or g tissue (Fig. 5). At
2 h post-gavage, pelargonidin glucuronide was the major
metabolite detected in kidney and liver, with levels reaching
0·5 and 0·15 nmol pelargonidin equivalents/g tissue, respect-
ively (Fig. 5(a)). Whereas the brain and the lungs showed
the aglycone as the main metabolite with similar levels reach-
ing 0·16 nmol/g, in other tissues, mainly the spleen and heart,
no compounds were detected. At 18 h post-gavage, our tissue
analyses did not reveal the presence of any detectable levels of
pelargonidin aglycone or its glucuronides. However, the colo-
nic metabolite p-hydroxybenzoic acid was present in plasma,
reaching 44% of total metabolites detected at 2 h post-
gavage, and being the only metabolite detected in plasma at
18 h post-gavage (Fig. 5(b)).
Table 1 shows the levels of metabolites detected in different
parts of the gastrointestinal tract at 2 and 18 h following the
administration of pelargonidin to rats. Analyses of the stomach
content following the administration of pelargonidin demon-
strated the presence of p-hydroxybenzoic acid, which accounts
for approximately 11% of the detected compounds. High
levels of glucuronides were detected in the small intestine
tissue extract 2 h post-gavage. At 18 h post-gavage, these
metabolites disappeared completely from the small intestine,
which would be consistent with the time-dependency of pas-
sage through the gastrointestinal tract. However, p-hydroxy-
benzoic acid was detected in the large intestine, both at 2
and 18 h post-gavage (Table 1).
Analysis of urine samples obtained by aspirating the urine
directly from the rat bladder 2 h post-gavage demonstrated
the presence of pelargonidin glucuronide as the only metab-
olite excreted into the urine at this time. However, p-hydroxy-
benzoic acid constituted approximately 50% of metabolites
found in urine collected for 18 h post-gavage (Table 2). In
contrast to the urine, the glucuronide conjugates were not
found in any of the faecal samples, with p-hydroxybenzoic
acid as the major product. The results reveal that the total
recovery of the administered pelargonidin was only 18%
m/z
Fig. 3. Mass spectra of the derivatised derivatives of p-hydroxybenzoic acid as detected in urine. The spectra shows a characteristic fragment at m/z ¼ 309,
resulting from the loss of a t-butyl group of the derivatised compound. The identification was done by comparison with the spectra of the purified standard.
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after 2 h, where the majority of the detected levels were
located in the stomach; however, the amounts recovered
dropped to 1·2% only 18 h post-gavage, with the urine and
faecal content constituting almost 90% of the total recovered
pelargonidin.
Discussion
Recently, much attention has been given to the biological
functions of flavonoids. Foods that are rich in anthocyanins
have been shown to exert multiple beneficial health effects.
In this context, the bioavailability of anthocyanins represents
a timely question that we were aiming to address by conduct-
ing the present study on the absorption, metabolism, distri-
bution and excretion of pelargonidin.
Our results demonstrated that pelargonidin was absorbed
from the gastrointestinal tract and it appeared in the plasma
and urine mainly as a glucuronidated conjugate. It has been
well documented previously that anthocyanidins are absorbed,
in both man and animals, as their intact glycosidic forms pre-
sent in fruit (Miyazawa et al. 1999; Tsuda et al. 1999).
Despite this, various glucuronide conjugates of cyanidin
(Wu et al. 2002) as well as pelargonidin (Felgines et al.
2003) have been detected in human plasma previously follow-
ing the intake of elderberries and strawberries. The mechanism
of glucuronide formation from the anthocyanidin glucoside
was reported to involve the conversion of the glucoside
directly into its corresponding glucuronide (Wu et al. 2002)
by the action of UDP-glucose dehydrogenase. Furthermore,
anthocyanidin glucosides can be hydrolysed yielding the agly-
cone, which can be subject to glucuronidation in the intestine
and liver. Interestingly, the presence of cyanidin aglycone has
been previously reported in the rat jejunum after ingestion of
cyanidin-3-glucoside (Tsuda et al. 1999). The ingestion of
pelargonidin aglycone and the ensuing detection of circulating
pelargonidin glucuronides, in the present study, provides evi-
dence that the flavylium cation structure does not impart
resistance to enzymatic conversion by UDP-glucuronosyl
transferase, as previously assumed by Miyazawa et al. (1999).
In spite of detecting pelargonidin and its glucuronide in rat
plasma and tissues 2 h after administration, neither the native
compound nor its metabolites were found 18 h after ingestion.
A pharmacokinetic study regarding the absorption of antho-
cyanins has previously demonstrated that these compounds
Fig. 4. Possible mechanism for degradation of pelargonidin leading to formation of p-hydroxybenzoic acid. · · ·Q, breakage of C-ring between C8a-O1 and
C2-C3 leading to formation of p-hydroxybenzoic acid. – – – Q, breakage between O1-C2 and C4-C4a leading to the formation of p-hydroxyphenyl propionic
acid.
Fig. 5. Concentrations of pelargonidin and its metabolites (calculated as
nmol pelargonidin equivalents) in rat tissues obtained 2 h (a) and plasma
obtained at 2 and 18 h (b) after oral administration of 50mg/kg body weight
of pelargonidin. For details of procedures, see p. 52. (a), Pelargonidin in free
(B) and conjugated forms (p); (b), pelargonidin in conjugated forms (r) and
p-hydroxybenzoic acid (b). Values are means with their standard errors
depicted by vertical bars (six animals per group).
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are rapidly absorbed; reaching maximum plasma concen-
trations of 3·49mM at 15min after a single oral dose was
administered to rats. Thereafter the plasma concentration fell
rapidly reaching 0·14mMat 240min, and thus suggesting a
relatively short half-life (Miyazawa et al. 1999). Rapid
absorption could be attributed to the involvement of
stomach-dependent mechanisms, possibly through a bilitran-
slocase-mediated mechanism as indicated following adminis-
tration of grape anthocyanins to rats (Passamonti et al.
2003). The high instability of anthocyanidins at physiological
pH and their rapid decomposition to ring-opened forms and/or
degradation products is probably responsible for the relatively
short half-life in biological fluids. Indeed, it was recently
shown that the flavylium cation form is not regenerated by
acidification following incubation of aglycones with control
urine or plasma (Felgines et al. 2002).
One of the major findings of the present study was the
identification of p-hydroxybenzoic acid as an important
metabolite of pelargonidin in the rat plasma and gastrointesti-
nal tissues. Despite the fact that this metabolite could also be
derived from the metabolism of other compounds such as aro-
matic amino acids, the high levels detected post-gavage of
pelargonidin, as compared with levels detected in control ani-
mals, support the notion that this phenolic acid commonly
arises from the metabolism of pelargonidin. Indeed, a structu-
rally similar metabolite, namely protocatechuic acid, was
detected following an oral cyanidin glucoside administration
to rats, with plasma levels reaching eight times that of the
anthocyanidin (Tsuda et al. 1999). The detection of p-hydro-
xybenzoic acid in stomach extract and plasma 2 h after
gavage indicates that its formation likely results due to the
instability and degradation of the anthocyanidin. However,
phenolic acid derivatives may also be formed by the colonic
microflora. A comparison of the metabolites formed after
oral and intraperitoneal administration of catechin, and the
suppression of their formation after administration of anti-
biotics, confirms the catabolising activities of colonic micro-
flora (Das & Griffiths, 1968). In addition, it was shown
recently that in vitro incubation of anthocyanins with human
faecal suspension yields phenolic acids as major products
(Fleschhut et al. 2005). Our results, demonstrating that a simi-
lar pathway exists in vivo, clearly point to the importance of
colonic metabolism of flavonoids. Indeed, these metabolites
might be equally as important since anticancer properties of
aromatic acids have been previously documented (Samid
et al. 1997; Thibout et al. 1999).
Considering all pelargonidin metabolites detected, the per-
centages of products excreted over 18 h accounted only for
1·2% of the gavaged dose. Similar findings were also reported
where total urinary excretion of blackberry anthocyanidins in
rats (Felgines et al. 2002) as well as strawberry anthocyanin
metabolites in human subjects (Felgines et al. 2003) corre-
sponded to only 0·93 and 1·8% of the anthocyanidins
ingested, respectively, pointing to the existence of other
non-detectable metabolites.
In conclusion, the present results suggest the importance of
investigating the biological activities of the degradation pro-
ducts, which could be formed at a later stage, possibly in
the colon, when evaluating the properties of diet-derived
anthocyanidins.
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